MorphoSys AG Logo

MorphoSys AG

MOR | F

Overview

Corporate Details

ISIN(s):
DE000A3H2XW6
LEI:
529900493806K77LRE72
Country:
Germany
Address:
Semmelweisstr. 7, 82152 Planegg
Sector:
Health Care
Industry:
Pharmaceuticals

Description

MorphoSys is a commercial-stage biopharmaceutical company dedicated to the discovery, development, and delivery of innovative cancer medicines. Our ambition is to redefine how cancer is treated. As a commercial-stage biopharmaceutical company, we are driven by the urgency to deliver groundbreaking medicines, aspiring to give more life for people with cancer.

Social Media

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2024-08-27 16:00
Regulatory News Service
Merger Squeeze-Out of MorphoSys Minority Shareholders Approved at 2024 Annual G…
English 11.5 KB
2024-08-05 07:30
Delisting Announcement
MorphoSys Completes Voluntary Delisting from the Frankfurt Stock Exchange and N…
English 12.1 KB
2024-07-19 16:46
General Meeting Notice
MorphoSys AG: Korrektur: Bekanntmachung der Einberufung zur Hauptversammlung am…
German 259.7 KB
2024-07-19 15:07
General Meeting Notice
MorphoSys AG: Bekanntmachung der Einberufung zur Hauptversammlung am 27.08.2024…
German 259.7 KB
2024-07-18 16:00
Declaration of Voting Results & Voting Rights Announcements
English 4.6 KB
2024-07-12 22:02
Delisting Announcement
MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market
English 13.2 KB
2024-07-12 14:34
Major Shareholding Notification
Ad hoc: Merger Squeeze-out Cash Compensation Determined at EUR 68.00
English 12.6 KB
2024-07-05 16:00
Report Publication Announcement
English 3.9 KB
2024-07-02 16:00
Declaration of Voting Results & Voting Rights Announcements
English 14.6 KB
2024-06-21 16:00
Declaration of Voting Results & Voting Rights Announcements
English 14.3 KB
2024-06-20 08:25
Delisting Announcement
MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merge…
English 21.4 KB
2024-06-20 08:06
Major Shareholding Notification
Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of …
English 12.3 KB
2024-06-10 16:01
Declaration of Voting Results & Voting Rights Announcements
English 13.4 KB
2024-06-10 16:00
Declaration of Voting Results & Voting Rights Announcements
English 13.4 KB
2024-06-06 22:19
Board/Management Change
Ad hoc: Arkadius Pichota and Lukas Gilgen appointed to Management Board of Morp…
English 10.9 KB

Insider Transactions

Date Insider Name Position Type Shares Value
2023-09-20 Cluzel, Dr. Marc Supervisory board Buy None 775.25 EUR
2023-06-07 Cluzel, Dr. Marc Supervisory board Buy None 52,800.00 EUR
2023-06-06 Cluzel, Dr. Marc Supervisory board Buy None 24,280.00 EUR
2022-11-30 Reissner, Thomas Supervisory board Buy None 13,800.00 EUR
2022-11-30 Reissner, Thomas Supervisory board Buy None 7,479.00 EUR
2022-11-30 Reissner, Thomas Supervisory board Buy None 4,186.00 EUR
2022-11-30 Reissner, Thomas Supervisory board Buy None 2,698.00 EUR
2022-11-29 Reissner, Thomas Supervisory board Buy None 8,100.00 EUR
2022-11-29 Reissner, Thomas Supervisory board Buy None 5,000.00 EUR
2022-11-28 Vermeylen, Krisja Supervisory board Buy None 14,860.00 EUR

Peer Companies

Company Country Ticker View
E.S. Australia Israel Holdings LTD Israel AUIS
EuroAPI Logo EuroAPI France EAPI
Eurofins-Cerep Logo Eurofins-Cerep France ALECR
EUROPEAN GREEN TRANSITION PLC Logo EUROPEAN GREEN TRANSITION PLC United Kingdom EGT
Evolear AB Logo Evolear AB Sweden EVOL
Faes Farma S.A. Logo Faes Farma S.A. Spain FAE
Fagron N.V. Logo Fagron N.V. Belgium FAGR
Farmak Logo Farmak Ukraine FARM
Farmsintez ao Logo Farmsintez ao Russian Federation LIFE
Financière de Tubize S.A. Logo Financière de Tubize S.A. Belgium TUBAT